DE69004561D1 - Zubereitung zur perkutanen anwendung. - Google Patents

Zubereitung zur perkutanen anwendung.

Info

Publication number
DE69004561D1
DE69004561D1 DE90912459T DE69004561T DE69004561D1 DE 69004561 D1 DE69004561 D1 DE 69004561D1 DE 90912459 T DE90912459 T DE 90912459T DE 69004561 T DE69004561 T DE 69004561T DE 69004561 D1 DE69004561 D1 DE 69004561D1
Authority
DE
Germany
Prior art keywords
ethyl
ester
pref
emedastine
esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE90912459T
Other languages
English (en)
Other versions
DE69004561T2 (de
Inventor
Hiroshi Nakagawa
Shoichi - - Harada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Publication of DE69004561D1 publication Critical patent/DE69004561D1/de
Application granted granted Critical
Publication of DE69004561T2 publication Critical patent/DE69004561T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE90912459T 1989-08-28 1990-08-23 Zubereitung zur perkutanen anwendung. Expired - Fee Related DE69004561T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1220788A JPH0383924A (ja) 1989-08-28 1989-08-28 経皮投与用組成物
PCT/JP1990/001073 WO1991003244A1 (en) 1989-08-28 1990-08-23 Composition for percutaneous administration

Publications (2)

Publication Number Publication Date
DE69004561D1 true DE69004561D1 (de) 1993-12-16
DE69004561T2 DE69004561T2 (de) 1994-04-28

Family

ID=16756579

Family Applications (1)

Application Number Title Priority Date Filing Date
DE90912459T Expired - Fee Related DE69004561T2 (de) 1989-08-28 1990-08-23 Zubereitung zur perkutanen anwendung.

Country Status (9)

Country Link
US (1) US5321022A (de)
EP (1) EP0440811B1 (de)
JP (1) JPH0383924A (de)
KR (1) KR920700647A (de)
AT (1) ATE97000T1 (de)
DE (1) DE69004561T2 (de)
DK (1) DK0440811T3 (de)
ES (1) ES2062545T3 (de)
WO (1) WO1991003244A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3527256B2 (ja) * 1992-12-09 2004-05-17 ロート製薬株式会社 抗アレルギー点眼剤
FR2727865B1 (fr) * 1994-12-08 1997-07-18 Esteve Labor Dr Utilisation des derives de 2-(4-(azolybutyl)-piperazinyl- (methyl))-benzimidazole et analogues ainsi que de leurs sels, pour la preparation de medicaments destines au traitement ou a la prophylaxie de l'asthme
EP0826371A4 (de) * 1995-04-27 2000-11-15 Akzo Nobel Nv Emedastin enthaltende äusserlich anzuwendende zubereitung
IT1318705B1 (it) * 2000-09-22 2003-08-27 Gianluigi Ciocca Medicamento transdermico ad alta penetrazione.
AUPS317302A0 (en) * 2002-06-25 2002-07-18 Drug Delivery Solutions Pty Ltd Metastable pharmaceutical compositions
KR20050045946A (ko) 2002-06-25 2005-05-17 애크럭스 디디에스 피티와이 리미티드 비정질 약학적 조성물을 이용한 경피전달속도의 제어
KR101774084B1 (ko) 2011-04-18 2017-09-01 히사미쓰 세이야꾸 가부시키가이샤 첩부제의 제조 방법 및 첩부제
KR101902612B1 (ko) 2012-10-11 2018-09-28 히사미쓰 세이야꾸 가부시키가이샤 첩부제
US20160354322A1 (en) 2014-01-31 2016-12-08 Hisamitsu Pharmaceutical Co., Inc. Emedastine-Containing Tape Preparation
WO2017061393A1 (ja) * 2015-10-06 2017-04-13 久光製薬株式会社 貼付剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
JPS5879983A (ja) * 1981-11-06 1983-05-13 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
JPH0764754B2 (ja) * 1984-10-02 1995-07-12 花王株式会社 経皮吸収促進剤及びこれを含有する皮膚外用剤
JPH01207246A (ja) * 1988-02-12 1989-08-21 Nissan Chem Ind Ltd 外用製剤用基剤組成物及び外用医薬組成物
JPH06185328A (ja) * 1992-03-01 1994-07-05 Otix:Kk 可変バルブタイミング・リフト機構

Also Published As

Publication number Publication date
DE69004561T2 (de) 1994-04-28
DK0440811T3 (da) 1993-12-27
EP0440811A4 (en) 1992-01-02
JPH0383924A (ja) 1991-04-09
EP0440811B1 (de) 1993-11-10
ES2062545T3 (es) 1994-12-16
US5321022A (en) 1994-06-14
EP0440811A1 (de) 1991-08-14
WO1991003244A1 (en) 1991-03-21
ATE97000T1 (de) 1993-11-15
KR920700647A (ko) 1992-08-10

Similar Documents

Publication Publication Date Title
DE69004561D1 (de) Zubereitung zur perkutanen anwendung.
MY110765A (en) Compositions containing cholesteryl esters of unsaturated fatty acids
DE3772899D1 (de) Reinigungsmittel.
SE8405929L (sv) Farmaceutisk komposition
AU543727B2 (en) Injectable composition of rapamycin
AU2110588A (en) Esters and amides of cyclic carboxylic acids and cyclic alcohols and amines
AU5829186A (en) 2-thio or oxo-4-aryl or heterocyclo-1,5 (2h)- pyrimidinedi-carboxylic acid diesters and 3-acyl-5- pyrimidinecarboxylic acids and esters
NO894465D0 (no) Preparat med oekt penetrasjon gjennom huden.
IE893718L (en) Pharmaceutical Compositions
ES2087471T3 (es) Esteres gelan.
GB1365398A (en) Stick for the application of adhesive to substrates
AU3674589A (en) Skin- or hair-care compositions containing silica and carboxylic acid esters
HUT51105A (en) Pesticide comprising substituted acrylic acid ester derivatives as active ingredient and process for producing the active ingredients
HUT42691A (en) Process for preparing carboxylic acid ester derivatives and insecticidal preparations containing the same as active substance
DE3666807D1 (en) Process for the preparation of esters of alpha-ethylenically unsaturated alcohols and alpha-ethylenically unsaturated carboxylic acids
NO177422C (no) Fremgangsmåte for racemisering av ikke-racemiske 3-oksocyklopentan- resp. - heksan-karboksylsyrer eller deres estere med C1-C6 alkoholer
KR930001889A (ko) 갈랑긴의 안정화 방법
ES2161898T3 (es) Utilizacion de al menos un acido graso contra la puesta de lepidopteros tortris.
AU2300588A (en) Caffeic acid esters and method of preparing and using same
HU9300112D0 (en) Method for stabilizing esters of unsaturated carboxylic acids
EP0270282A3 (de) Ölsäure-Ester und pharmazeutische Zusammenstellungen
GB9222655D0 (en) Method for the safe administration of fatty acids and theirlithium salts
GR65285B (en) Method for the preparation of optically active salts and the lacton of cis-2-hydroxy-cyclopent-4en-1yl of acetic acid

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee